The Latest
Health
India Caps How Fast Most Medicine Prices Rise, Not Where They Start
The Supreme Court has reserved its order on why most medicines sit outside India's price control regime. For about four fifths of sales by value, the law limits yearly increases and leaves the starting price to the manufacturer.
October 28, 2026
Markets
Jio's 27 Percent Debut Gain Says Little About What Holders Will Earn
Jio closed its first session about 27 percent above its issue price, behind only LG Electronics India and Coal India among the giants. The earlier mega-issues show how little that number has told holders about what came next.
October 28, 2026
Business
India's New Container Scheme Targets Under an Eighth of China's Output
The Cabinet cleared Rs 10,000 crore to build containers at home. The 7.5 lakh TEU target equals 11.6 percent of what China built in 2025, so the scheme buys resilience, not independence.
October 28, 2026
Business
Tata Motors Won Iveco but Stopped Short of Owning It
Tata Motors cleared the 80 percent bar for Iveco, but 89.42 percent is not the 95 percent that ends the process. The €3.91 billion it is paying buys a business whose profit is shrinking.
October 27, 2026
Technology
Microsoft Is Offering a Quarter of Its Staff a Way Out as Profit Rises
Microsoft is offering buyouts to about 60,000 employees, including in India, in a year its operating income rose 21%. At the take-up rates on record, the offer would move 1% to 8% of its workforce.
October 27, 2026
Technology
India's Smartphone Market Fell to a Decade Low, and Chinese Brands Took the Hit
Shipments fell 26% to a decade low even in festive season. The brands built on thin margins and cheap memory lost the most, while Samsung and Apple held the premium end.
October 27, 2026
Business & Markets
Business
India's GST Refund Backlog Was Already Almost Gone Before the 90 Percent Advance
GST refund claims pending over 90 days fell from 1,592 to 110 in two years, so the new 90 percent advance fixes a backlog that is mostly cleared. The rule that will change behaviour from 1 November is the one on post-sale discounts.
October 28, 2026
Business
India's New Container Scheme Targets Under an Eighth of China's Output
The Cabinet cleared Rs 10,000 crore to build containers at home. The 7.5 lakh TEU target equals 11.6 percent of what China built in 2025, so the scheme buys resilience, not independence.
October 28, 2026
Business
Tata Motors Won Iveco but Stopped Short of Owning It
Tata Motors cleared the 80 percent bar for Iveco, but 89.42 percent is not the 95 percent that ends the process. The €3.91 billion it is paying buys a business whose profit is shrinking.
October 27, 2026
Technology & Science
Technology
Microsoft Is Offering a Quarter of Its Staff a Way Out as Profit Rises
Microsoft is offering buyouts to about 60,000 employees, including in India, in a year its operating income rose 21%. At the take-up rates on record, the offer would move 1% to 8% of its workforce.
October 27, 2026
Technology
India's Smartphone Market Fell to a Decade Low, and Chinese Brands Took the Hit
Shipments fell 26% to a decade low even in festive season. The brands built on thin margins and cheap memory lost the most, while Samsung and Apple held the premium end.
October 27, 2026
Technology
India's PC Growth Was Buyers Stocking Up Before the Price Hikes
India's PC market grew 12.1% in the June quarter. Global shipments then fell about 20% in the September quarter. The first number was buyers racing the price hikes, and the second is the bill.
October 24, 2026
Health, Culture & Geopolitics
Health
India Caps How Fast Most Medicine Prices Rise, Not Where They Start
The Supreme Court has reserved its order on why most medicines sit outside India's price control regime. For about four fifths of sales by value, the law limits yearly increases and leaves the starting price to the manufacturer.
October 28, 2026
Health
The Malaria Vaccine With a 40 Percent Price Cut Still Costs Twice as Much as Its Rival
Gavi and UNICEF cut the price of the Mosquirix malaria vaccine by about 40 percent to 5.50 euros a dose. Its rival R21 is $2.99, and WHO says neither performs better. The deal is conditional on a manufacturing move to India's Bharat Biotech.
October 23, 2026
Health
India's Measles Protection Reads 95 Percent in One Count and 72 in Another
Bangladesh has recorded 1,189 measles deaths this year after a vaccine stockout. India's headline immunisation numbers look safe, but the survey underneath them is less comforting.
October 22, 2026